Lee Byoung Chul, Park In Ja, Kim Chan Wook, Lim Seok-Byung, Yu Chang Sik, Kim Jin Cheon
Division of Colon and Rectal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ann Surg Treat Res. 2017 Apr;92(4):200-207. doi: 10.4174/astr.2017.92.4.200. Epub 2017 Mar 24.
To investigate patterns of recurrence and oncologic outcomes after recurrence between preoperative and postoperative chemoradiotherapy (CRT).
Records of patients with stage II or III locally advanced rectal cancer seen between January 2000 and December 2010 were analyzed. The outcomes for patients undergoing preoperative CRT followed by radical resection (n = 466) were compared with outcomes of patients matched for sex, age, and stage who had surgery and then postoperative CRT (n = 466). Recurrence rates and sites, treatment of recurrence, and oncologic outcomes after recurrence were investigated. The rate of sphincter preservation and permanent stoma formation were also evaluated.
Recurrence occurred in 124 and 140 patients in the pre- and postoperative CRT groups, respectively. The local and systemic recurrence rates were 3.6% and 20.8%, respectively, in the preoperative CRT group and 3.0% and 25.3%, respectively, in the postoperative CRT group (P = 0.245). Time to recurrence was longer in the postoperative CRT group (19 months . 24.2 months, P = 0.029). The overall rates of sphincter preservation (sphincter preservation operation and postoperative permanent stoma formation) did not significantly different between the two groups (P = 0.381). The 5-year overall survival rate after recurrence did not differ between the two groups (25.6% . 18.6%, P = 0.051).
Preoperative and postoperative CRT are both safe and suitable treatment methods for rectal cancer, so the choice can be tailored to the patient's situation.
探讨术前与术后放化疗(CRT)后复发模式及复发后的肿瘤学结局。
分析2000年1月至2010年12月期间II期或III期局部晚期直肠癌患者的记录。将接受术前CRT后根治性切除的患者(n = 466)的结局与性别、年龄和分期匹配的先手术然后接受术后CRT的患者(n = 466)的结局进行比较。研究复发率和复发部位、复发的治疗以及复发后的肿瘤学结局。还评估了括约肌保留率和永久性造口形成率。
术前CRT组和术后CRT组分别有124例和140例患者复发。术前CRT组的局部和全身复发率分别为3.6%和20.8%,术后CRT组分别为3.0%和25.3%(P = 0.245)。术后CRT组的复发时间更长(19个月对24.2个月,P = 0.029)。两组间括约肌保留的总体率(括约肌保留手术和术后永久性造口形成)无显著差异(P = 0.381)。两组复发后的5年总生存率无差异(25.6%对18.6%,P = 0.051)。
术前和术后CRT都是直肠癌安全且合适的治疗方法,因此可根据患者情况进行选择。